Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 4 Comparison between the studied groups according to SLICC damage index, SLEDAI and antiphospholipid syndrome

From: Neuropsychiatric lupus erythematosus in a cohort of Egyptian patients

 

Group I (n = 68)

Group II (n = 66)

p

SLICC calculated

 Median (Min.–Max.)

2 (0–6)

1 (0–6)

 

 Mean ± SD

1.9 ± 1.7

1.4 ± 1.3

0.067

SLEDAI

 Median (Min.–Max.)

4 (0–37)

4 (0–29)

 

 Mean ± SD

7.4 ± 9.6

6.3 ± 7.5

0.952

Antiphospholipid syndrome

17 (25%)

7 (10.6%)

0.030*

  1. SLICC Systemic Lupus International Collaborating Clinics Damage Index score, SLEDAI SLE Disease Activity Index
  2. χ2: Chi square test
  3. p: p value for comparing between the studied groups; *: Statistically significant at p ≤ 0.05
Back to article page